pingish

Dendreon: The Next Genentech/Amgen?

This story is pretty much garbage. Anyone who understands biotech understands that there are few proven paths from biotechnology research outfit to biotech giant. DNDN has taken the first step of a long marathon on which <b>many</b>... have embarked and five have finished. This story would be more credible if the journalist outlines the prescription for growing into a biotech giant and show how DNDN has moved it's chess pieces forward. Until then, this is just pre-FDA-decision babble.